Stimulation tear secretion treatment dry-eye disease effect IBMX secretagogue tear secretion dry-eye disease clinical study IBMX dose-dependent decrease tear film osmolarity significant mmol/L patients dry-eye disease effect prior administration proparacaine hydrochloride open-label vehicle-controlled study IBMX tear film osmolarity whereas vehicle weeks mean SEM osmolarity IBMX-treated eyes mOsm/L mOsm/L unchanged vehicle-treated eyes mOsm/L vs mOsm/L study IBMX effective vehicle bengal staining Hence topical IBMX tear secretion ocular surface disease patients dry-eye disease 